Literature DB >> 27133733

Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.

Alejandra Hurtado-de-Mendoza1, Mark L Cabling2, Tania Lobo1, Chiranjeev Dash1, Vanessa B Sheppard1.   

Abstract

Adjuvant hormone therapy contributes to reductions in recurrence and mortality for women with hormone receptor-positive breast cancer. However, adherence to hormone therapy is suboptimal. This is the first systematic literature review examining interventions aimed at improving hormone therapy adherence. Researchers followed the PRISMA guidelines. PubMed-Medline, CINAHL, PsychInfo, Ovid-Medline, and EMBASE were searched for behavioral interventions that aimed to enhance adherence to adjuvant hormone therapy in breast cancer survivors. A total of 376 articles were screened for eligibility. Five articles met the study criteria. All interventions presented adherence outcomes after 1-year follow-up. None significantly enhanced adherence compared to the usual care in the primary analysis (odds ratios ranged from 1.03 to 2.06 for adherence and from 1.11 to 1.18 for persistence). All studies targeted patients, and only 3 studies included postmenopausal breast cancer patients. Three tested the same intervention consisting of educational materials. Only one was conducted in the United States. Only one reported participants' ethnicity. Overall, it was unclear whether the studies contained bias. The use of different terminology and operationalization of adherence made comparisons challenging. Interventions to improve adherence to adjuvant hormone therapy in US breast cancer populations that include survivors who are ethnically diverse, premenopausal, and receiving tamoxifen therapy are necessary to inform future interventions. Adoption of consistent adherence definitions/measurements will provide a clearer framework to consolidate aggregate findings. Given the limited efficacy of tested interventions, it is important to engage oncologists and researchers to develop approaches that target different components associated with hormone therapy adherence, such as doctor-patient communication or social support.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast neoplasm; Clinical trials; Compliance; Patients; Systemic therapy

Mesh:

Substances:

Year:  2016        PMID: 27133733      PMCID: PMC4969158          DOI: 10.1016/j.clbc.2016.03.006

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  48 in total

Review 1.  Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.

Authors:  Jessica Howard-Anderson; Patricia A Ganz; Julienne E Bower; Annette L Stanton
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

3.  A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians.

Authors:  Laetitia Huiart; Cyril Ferdynus; Roch Giorgi
Journal:  Breast Cancer Res Treat       Date:  2013-02-12       Impact factor: 4.872

Review 4.  Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence.

Authors:  Alexander S Misono; Sarah L Cutrona; Niteesh K Choudhry; Michael A Fischer; Margaret R Stedman; Joshua N Liberman; Troyen A Brennan; Sachin H Jain; William H Shrank
Journal:  Am J Manag Care       Date:  2010-12       Impact factor: 2.229

5.  Missed opportunities: racial disparities in adjuvant breast cancer treatment.

Authors:  Nina A Bickell; Jason J Wang; Soji Oluwole; Deborah Schrag; Henry Godfrey; Karen Hiotis; Jane Mendez; Amber A Guth
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

Review 6.  Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.

Authors:  Lorena Rocha Ayres; André de Oliveira Baldoni; Anna Paula de Sá Borges; Leonardo Régis Leira Pereira
Journal:  Int J Clin Pharm       Date:  2013-08-11

7.  Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.

Authors:  Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly
Journal:  Breast Cancer Res Treat       Date:  2012-12-23       Impact factor: 4.872

8.  Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

Authors:  Katherine L Kahn; Eric C Schneider; Jennifer L Malin; John L Adams; Arnold M Epstein
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

9.  Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.

Authors:  Katherine D Crew; Jillian L Capodice; Heather Greenlee; Arlyn Apollo; Judith S Jacobson; George Raptis; Kimberly Blozie; Alex Sierra; Dawn L Hershman
Journal:  J Cancer Surviv       Date:  2007-10-12       Impact factor: 4.442

10.  Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation.

Authors:  Kathleen Ell; Betsy Vourlekis; Bin Xie; Frances R Nedjat-Haiem; Pey-Jiuan Lee; Laila Muderspach; Christy Russell; Lawrence A Palinkas
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

View more
  21 in total

1.  Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.

Authors:  Shirley M Bluethmann; Caitlin C Murphy; Jasmin A Tiro; Michelle A Mollica; Sally W Vernon; Leona Kay Bartholomew
Journal:  Oncol Nurs Forum       Date:  2017-05-01       Impact factor: 2.172

2.  Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review.

Authors:  Shoshana M Rosenberg; Keith J Petrie; Annette L Stanton; Lan Ngo; Emma Finnerty; Ann H Partridge
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

3.  The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.

Authors:  Joan M Neuner; Nicole M Fergestrom; Purushottam W Laud; Ann B Nattinger; Kirsten M M Beyer; Kathryn E Flynn; Liliana E Pezzin
Journal:  Cancer       Date:  2019-08-02       Impact factor: 6.860

4.  A systematic review of interventions to improve adherence to endocrine therapy.

Authors:  Sue P Heiney; Pearman D Parker; Tisha M Felder; Swann Arp Adams; Omonefe O Omofuma; Jennifer M Hulett
Journal:  Breast Cancer Res Treat       Date:  2018-11-01       Impact factor: 4.872

5.  Providers' Perspectives on Adherence to Hormonal Therapy in Breast Cancer Survivors. Is there a Role for the Digital Health Feedback System?

Authors:  Alejandra Hurtado de Mendoza; Mark Cabling; Asma Dilawari; Jeanine W Turner; Nicole Fernández; Alesha Henderson; Qi Zhu; Sara Gómez; Vanessa B Sheppard
Journal:  Health Technol (Berl)       Date:  2018-10-05

6.  Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.

Authors:  Dawn L Hershman; Joseph M Unger; Grace Clarke Hillyer; Anna Moseley; Kathryn B Arnold; Shaker R Dakhil; Benjamin T Esparaz; Ming C Kuan; Mark L Graham; Douglas M Lackowski; William J Edenfield; Zoneddy R Dayao; N Lynn Henry; Julie R Gralow; Scott D Ramsey; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2020-05-05       Impact factor: 50.717

7.  Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.

Authors:  Kirsti I Toivonen; Devesh Oberoi; Kathryn King-Shier; Katherine-Ann L Piedalue; Joshua A Rash; Linda E Carlson; Tavis S Campbell
Journal:  Curr Oncol       Date:  2021-07-05       Impact factor: 3.677

8.  Study design and methods for the using exercise to relieve joint pain and improve AI adherence in older breast cancer survivors (REJOIN) trial.

Authors:  Shirley M Bluethmann; Cristina Truica; Heidi D Klepin; Nancy Olsen; Christopher Sciamanna; Vernon M Chinchilli; Kathryn H Schmitz
Journal:  J Geriatr Oncol       Date:  2021-05-26       Impact factor: 3.929

9.  Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.

Authors:  Yiqi Pan; Sarah R Heisig; Pia von Blanckenburg; Ute-Susann Albert; Peyman Hadji; Winfried Rief; Yvonne Nestoriuc
Journal:  Breast Cancer Res Treat       Date:  2018-01-12       Impact factor: 4.872

10.  Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.

Authors:  W Wulaningsih; H Garmo; J Ahlgren; L Holmberg; Y Folkvaljon; A Wigertz; M Van Hemelrijck; M Lambe
Journal:  Breast Cancer Res Treat       Date:  2018-07-21       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.